American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992; 117:1038.
Andersson, B, Mattsson, LA, Hahn, L, et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82:638.
Andersson, K, Mattsson, L, Rybo, G, et al. Intrauterine release of levonorgestrel. A new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992; 79:963.
Andersson, K, Stadberg, E, Mattsson, LA, Rybo, G. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women-effects on lipid metabolism during 12 months of treatment. Int J Fertil 1996; 41:476.
Archer, DF, Pickar, JH, Bottiglioni, F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 1994; 83:686.
Baird, DT, Glasier, AF. Hormonal contraception. N Engl J Med 1993; 328:1543.
Baker, VL. Alternatives to oral estrogen replacement: Transdermal patches, percutaneous gels, vaginal creams and rings, implants, and other methods of delivery. Obstet Gynecol Clin North Am 1994; 21:271.
Bar, J, Tepper, R, Fuchs, J, et al. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 1993; 81:261.
Barrett-Connor, E, Silverstein, D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637.
Barrett-Connor, E, Wingard, DL, Criqui, MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, California, revisited. JAMA 1989; 261:2095.
Belchetz, PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330:1062.
Beresford, SA, Weiss, NS, Voigt, LF, McKnight, B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 1997; 349:458.
Bergkvist, L, Adami, H-O, Persson, I, et al. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 1989; 130:221.
Bergkvist, L, Adami, HO, Persson, I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989; 321:293.
Bhatia, NN, Bergman, A, Karram, MM. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989; 160:176.
Black, LJ, Sato, M, Rowley, ER, et al. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 1994; 93:63.
Brenner, DE, Kukull, WA, Stergachis, A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study. Am J Epidemiol 1994; 140:262.
Brincat, M, Versi, E, Moniz, CF, et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70:123.
Bush, TL, Barrett-Connor, E, Cowan, LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75:1102.
Casson, PR, Carson, SA. Androgen replacement therapy in women: Myths and realities. Int J Fertil 1996; 41:412.
Cauley, JA, Lucas, FL, Kuller, LH. Bone mineral density and risk of breast cancer in older women. JAMA 1996; 276:1404.
Cerin, A, Heldaas, K, Moeller, B, for the Scandinavian LongCycle Study Group. Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy (letter). N Engl J Med 1996; 334:668.
Chen, SJ, Li, H, Durand, J, et al. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996; 93:577.
Chetkowski, RJ, Meldrum, DR, Steingold, KA, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986; 314:1615.
Christiansen, C, Christensen, MS, Transbol, I. Bone mass in postmenopausal women with withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; 1:459.
Christiansen, C, Riis, BJ. 17-B estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990; 71:836.
Christiansen, C, Riis, BJ. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins and bleeding patterns. Br J Obstet Gynaecol 1990; 97:1087
Chu, J, Schweid, AI, Weiss, NS. Survival among women with endometrial cancer: A comparison of estrogen users and nonusers. Am J Obstet Gynecol 1982; 143:569.
Clarkson, TB, Anthony, MS, Klein, KP. Effects of estrogen treatment on arterial wall structure and function. Drugs 1994; 47(Suppl):42.
Clisham, PR, Cedars, MI, Greendale, G, et al. Long-term transdermal estradiol therapy: Effects on endometrial histology and bleeding patterns. Obstet Gynecol 1992; 79:196.
Clisham, PR, deZiegler, D, Lozano, K, et al. Comparison of sequential versus continuous estrogen and progestin replacement therapy in post-menopausal women. Obstet Gynecol 1991; 77:241.
Col, NF, Eckman, MH, Karas, RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997; 277:1140.
Colditz, GA, Hankinson, SE, Hunter, DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332:1589.
Collins, P, Rosano, GM, Sarrel, PM, et al. 17ß-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92:24.
Creasman, WT, Henderson, D, Hinshaw, W, Clarke-Pearson, DL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986; 67:326.
Crook, D, Cust, MP, Gangar, KF, et al. Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins. Am J Obstet Gynecol 1992; 166:950.
Cummings, SR, Black, DM, Nevitt, MC, et al. Study of Osteoporotic Fractures Research Group. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341:72.
Cyriak, D, Wong, CH. Mammographic changes in postmenopausal women undergoing hormone replacement therapy. Am J Radiol 1993; 161:1177.
Daly, E, Vessey, MP, Hawkins, MM, et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348:977.
DiSaia, PJ, Grosen, EA, Kurosaki, T, et al. Hormone replacement therapy in breast cancer survivors: A cohort study. Am J Obstet Gynecol 1996; 174:1494.
Ditkoff, EC, Crary, WG, Cristo, M, Lobo, RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78:991.
Draper, MW, Flowers, DE, Huster, WJ, et al. A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res 1996; 11:835.
Dupont, WD, Page, DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151:67.
Eiken, P, Kolthoff, N, Nielsen, SP. Effects of 10 years' hormone replacement on bone mineral content in postmenopausal women. Bone 1996; 19:191S.
Elkind-Hirsch, KE, Sherman, LD, Malinak, R. Hormone replacement therapy alters insulin sensitivity in young women with premature ovarian failure. J Clin Endocrinol Metab 1993; 76:472.
Ettinger, B, Friedman, GD, Bush, T, et al. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996; 87:6.
Ettinger, B, Selby, J, Citron, JT, et al. Cyclic hormone replacement therapy using quarterly progestin. Obstet Gynecol 1994; 83:693.
Falkeborn, M, Persson, I, Adami, HO et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynecol 1992; 99:821.
Fantl, JA, Cardozo, L, McClish, DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 1994; 83:12.
Farish, E, Spowart, K, Barnes, JF, et al. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein (a) and LDL subfractions. Atherosclerosis 1996; 126:77.
Finucane, FF, Madans, JH, Bush, TL, et al. Decreased risk of stroke among postmenopausal hormone users: Results from a national cohort. Arch Intern Med 1993; 153:73.
Fuleihan, G, Brown, EM, Curtis, K. Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism. Arch Intern Med 1992; 152:1904.
Gambrell Jr, RD, Maier, RC, Sanders, BI. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 1983; 62:435.
Gilligan, DM, Quyyumi, AA, Cannon, RO III. Effects of physiologic levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89:2545.
Ginsburg, ES, Owen, WF, Jr, Greenberg, LM, et al. Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease. J Clin Endocrinol Metab 1996; 81:4414.
Godsland, IF, Crook, D, Simpson, R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323:1375.
Grey, A, Cundy, T, Evans, M, Reid, I. Medroxyprogesterone acetate enhances the spine bone mineral density response to oestrogen in late postmenopausal women. Clin Endocrinol 1996; 44:293.
Grey, AB, Cundy, TF, Reid, IR. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in postmenopausal osteoporosis. Clin Endocrinol (Oxf) 1994; 40:671.
Grey, AB, Stapleton, JP, Evans, MC, et al. The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women. J Clin Endocrinol Metab 1995; 80:3191.
Grey, AB, Stapleton, JP, Evans, MC, et al. The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women. Am J Med 1995; 99:636.
Grodstein, F, Colditz, GA, Stampfer, MJ. Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol 1994; 83:5.
Grodstein, F, Smampfer, MJ, Goldhaber, SZ, et al. Prospective study of exogenous hormones and pulmonary embolism in women. Lancet 1996; 348:983.
Grodstein, F, Stampfer, MJ, Manson, J, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335:453.
Gruchow, HW, Anderson, AJ, Barboriak, JJ, Sobocinski, KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115:954.
Haarbo, J, Leth-Espensen, P, Stender, S, Christiansen, C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991; 87:1274.
Haarbo, J, Marslew, U, Gotfredsen, A, Christiansen, C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40:1323.
Hargrove, JT, Maxson, WS, Wentz, AC, Burnett, LS. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone. Obstet Gynecol 1989; 73:606.
Harlap, S. The benefits and risks of hormone replacement therapy: An epidemiologic overview. Am J Obstet Gynecol 1992; 166:1986.
Hazzard, WR. Estrogen replacement and cardiovascular disease: Serum lipids and blood pressure effects. Am J Obstet Gynecol 1989; 161: 1847.
Henderson, BE, Paganini-Hill, A, Ross, RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151:75.
Hillard, TC, Siddle, NC, Whitehead, MI, et al. Continuous combined conjugated equine estrogen-progestogen therapy: Effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histological diagnosis. Am J Obstet Gynecol 1992; 167:1.
Hirvonen, E, Salmi, T, Puolakka, J, et al. Can progestin be limited to every third month only in postmenopausal women taking estrogen? Maturitas 1995; 21:39.
Holland, EF, Studd, JW, Mansell, JP, et al. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol 1994; 83:180.
Hong, MK, Romm, PA, Reagan, K, et al. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992; 69:176.
Isaacs, AJ, Britton, AR, McPherson, K. Utilization of hormone replacement therapy by women doctors. BMJ 1995; 311:1399.
Jick, H, Derby, LE, Myers, MW, et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348:981.
Jurgens, RW Jr, Downey, LJ, Abernethy, WD, et al. A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy. Am J Obstet Gynecol 1992; 167:459.
Kable, WT, Gallagher, JC, Nachtigal, L, et al. Lipid changes after hormone replacement therapy for menopause. J Reprod Med 1990; 35:512.
Keller, PJ, Holtz, E, Imthrun, B. A transdermal regimen for continuous combined hormone replacement therapy in the menopause. Maturitas 1992; 15:195.
Kim, JC, Jang, HC, Cho, DH, et al. Effects of hormone replacement therapy on lipoproteins and lipids in postmenopausal women. Arterioscler Thromb 1994; 14:275.
Kim, YD, Chen, B, Beauregard, J, et al. 17ß-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 1996; 94:2901.
Koh, KK, Mincemoyer, R, Bui, MN, et al. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 1997; 336:683.
Kotowicz, MA, Melton III, LJ, Cooper, C, et al. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 1994; 9:599.
Kritz-Silverstein, D, Barrett-Connor, E. Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA 1996; 275:46.
Kupperman, HS. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953; 13:688.
Kurman, RJ, Kaminski, PF, Norris, HJ. The behavior of endometrial hyperplasia: A long term study of 'untreated' hyperplasia in 170 patients. Cancer 1985; 56:403.
Lieberman, EH, Gerhard, MD, Uehata, A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121:936.
Lindsay, R, Bush, TL, Grady, D, et al. Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab 1996; 81:3829.
Lip, GY, Beevers, M, Churchill, D, Beevers, DG. Hormone replacement therapy and blood pressure in hypertensive women. J Human Hypertens 1994; 8:491.
Lobo, RA, Pickar, JH, Wild, RA, et al. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 1994; 84:987.
Lobo, RA. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1991; 73:925.
Luciano, AA, DeSouza, MJ, Roy, MP, et al. Evaluation of low dose estrogen and progestin therapy in post-menopausal women. J Reprod Med 1993; 38:207.
Luciano, AA, Turksoy, RN, Carleo, J, et al. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy. Obstet Gynecol 1988; 71:39.
MacLennan, AH, MacLennan, A, Wenzel, S, et al. Continuous low-dose oestrogen and progestogen hormone replacement therapy: A randomized trial. Med J Aust 1993; 159:102.
Magos, AL, Brincat, M, Studd, JWW, et al. Amenorrhea and endometrial atrophy with continuous oral estrogen and progesterone therapy in postmenopausal women. Obstet Gynecol 1985; 65:496.
Mandel, FP, Geola, FL, Meldrum, DR, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1983; 57:133.
Marsh, MS, Crook, D, Whitcroft, SIJ, et al. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins. Obstet Gynecol 1994; 83:19
Marshall, D, Johnell, O, Wedel, H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312:1254.
Marslew U, Overgaard, K, Riis, BJ, et al. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: Long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol 1992; 79:202.
Mashchak, CA, Lobo, RA, Dozono-Takano, R, et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982; 144:511.
Massafra, Buonocore, G, Gioia, D, et al. Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrheic women. J Clin Endocrinol Metab 1997; 82:173.
Mattson, RH, Cramer, JA, Darney, PD, Naftolin, F. Use of oral contraceptives by women with epilepsy. JAMA 1986; 256:238.
Medical Research Council's General Practice Framework. Randomised comparison of oestrogen verus oestrogen plus progestogen replace therapy in women with hysterectomy. BMJ 1996; 312:473.
Moorjani, S, Dupont, A, Labrie, F, et al. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with ultrogestan in menopausal women. J Clin Endocrinol Metab 1991; 73:373.
Munk-Jensen, N, Ulrich, LG, Obel, EB, et al. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: Effect on plasma lipoproteins in a two year placebo controlled trial. Am J Obstet Gynecol 1994; 171:132.
Nabulsi, AA, Folsom, AR, Szklo, M, et al. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. No association of menopause and hormone replacement therapy with carotid atery intima-media thickness. Circulation 1996; 94:1857.
Nabulsi, AA, Folsom, AR, White, A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328:1069.
Newcomb, PA, Longnecker, MP, Storer, BE, et al. Long-term replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995; 142:788.
Notelovitz, M, Kitchens, C, Ware, M, et al. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation. Obstet Gynecol 1983; 62:596.
O'Keefe, JH, Kim, SC, Hall, RR, et al. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997; 29:1.
Obel, EB, Munk-Jensen, N, Svenstrup, B, et al. A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. Maturitas 1993; 16:13.
Oosterbaan, HP, van Burren, AHJAM, Schram, JHN, et al. The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women. Maturitas 1995; 21:211.
Ottosson, UB, Johansson, BG, von Schoultz, B. Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone. Am J Obstet Gynecol 1985; 151:746.
Paganini-Hill, A, Henderson, VW. Estrogen deficiency and the risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140:256.
Paganini-Hill, A. The benefits of estrogen replacement on oral health. The Leisure World cohort. Arch Intern Med 1995; 155:2325.
Pang, SC, Greendale, GA, Cedars, MI, et al. Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate. Fertil Steril 1993; 59:76.
Persson, I, Adami, H-O, Bergkvist, L, et al. Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens: Results of a prospective study. BMJ 1989; 298:147.
Petitti, DB, Perlman, JA, Sidney, S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol 1987; 70:289.
Petitti, DB, Wingerd, J, Pellegrin, F, Ramcharan, S. Risk of vascular disease in women: Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA 1979; 242:1150.
Place, VA, Powers, M, Darley, PE, et al. A double-blind comparative study of estraderm and premarin in the amelioration of postmenopausal symptoms. Am J Obstet Gynecol 1985; 152:1092.
Powles, TJ, Hickish, T, Kanis, JA, et al. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 1996; 14:78.
Prough, SG, Aksel, S, Wiebe, RH, et al. Continuous estrogen/progestin therapy in menopause. Am J Obstet Gynecol 1987; 157:1449.
Psaty, BM, Hackbert, SR, Atkins, D, et al. The risk of myocardial infarction associated with the combined use of estrogen and progestin in postmenopausal women. Arch Intern Med 1994; 154:1333.
Rauch, U, Taubert, HD. Continuous hormone replacement therapy with estradiol valerate and chlormadinone acetate in adjustable doses. A preliminary study. Maturitas 1993; 17:123.
Raudaskoski, TH, Lahti, EI, Kauppila, AJ, et al. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: Clinical and endometrial responses. Am J Obstet Gynecol 1995; 172:114.
Ravnikar, VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987; 156:1332.
Raz, R, Stamm, WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329:753.
Rincon, J, Holmang, A, Wahlstrom, EO, et al. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 1996; 45:615.
Rosano, GM, Sarrel, PM, Poole-Wilson, PA, Collins, P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342:133.
Sack, MN, Rader, DJ, Cannon, RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343:269.
Salamone, LM, Pressman, AR, Seeley, DG, et al. Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med 1996; 156:1293.
Saleh, AA, Dorey, LG, Dombrowski, MP, et al. Thrombosis and hormone replacement therapy in postmenopausal women. Am J Obstet Gynecol 1993; 169:1554.
Sarrel, PM, Lindsay, D, Rosano, GMC, Poole-Wilson, PA. Angina and normal coronary arteries in women: Gynecologic findings. Am J Obstet Gynecol 1992; 167:467.
Schiff, I, Sela, HK, Cramer, D, et al. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 1982; 37:79.
Shapiro, S, Kelly, JP, Rosenberg, L, et al. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 1985; 313:969.
Sillero-Arenas, M, Delgado-Rodriguez, M, Rodigues-Canteras, R, et al. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992; 79:286.
Spaulding, CB. Endometrial ablation for refractory postmenopausal bleeding with continuous hormone replacement. Fertil Steril 1994; 62:1181.
Speroff, L, Rowan, J, Symons, J, et al. The comparative effect on bone density, endometrium and lipids on continuous hormones as replacement therapy (CHART Study). JAMA 1996; 276:1397
Sporrong T, Hellgren, M, Samsioe, G, et al. Comparison of four continuously administered progestogen plus estradiol combinations for climacteric complaints. Br J Obstet Gynecol 1988; 95:1042.
Staland, B. Continuous treatment with a combination of estrogen and gestagen. A way of avoiding endometrial stimulation. Acta Obstet Gynecol Scand Suppl 1985; 130:29.
Stampfer, MJ, Colditz, GA, Willett, WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756.
Stanford, JL, Weiss, NS, Voigt, LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274:137.
Sullivan, JM, Vander Zwaag, R, Hughes, JP, et al. Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women. Arch Intern Med 1990; 150:2557.
Sullivan, JM, Vander Zwaag, R, Lemp, GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108:358.
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269:3015.
Tamaya, T, Misao, R, Nakagawa, M, et al. Estrogen and androgen receptors in aorta of the rabbit and regulation by estrogen and androgen. Res Commun Chem Pathol Pharmacol 1993; 82:3.
Tang, MX, Jacobs, D, Stern, Y, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348:429.
Taskinen, MR, Puolakka, J, Pyorala, T, et al. Hormone replacement therapy lower plasma Lp(a) concentrations. Arterioscler Thromb 1996; 16:1215.
The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114:545.
The Postmenopausal Estrogen/Progestin Interventions Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273:199.
The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA 1996; 275:370.
The Writing Group for the PEPI trial. Effects of hormone therapy on bone mineral density. Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1996; 276:1389.
Tilly-Kiesi, M, Lappi, M, Puolakka, J, et al. Different effects of continuous oestrogen-progestin and transdermal oestrogen with cyclic progestin regimens on low-density lipoprotein subclasses. Eur J Clin Invest 1996; 26:1125.
Tosteson, ANA, Rosenthal, DI, Melton III, LJ, Weinstein, MC. Cost effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy. Ann Intern Med 1990; 113:594.
Troisi, RJ, Speizer, FE, Willett, WC, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. Am J Respir Crit Care Med 1995; 152:1183.
Utian, WH, Schiff, I. NAMS-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1994; 1:39.
van Erpecum, KJ, van Berge Henegouwen, GP, Verschoor, L, et al. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women. Gastroenterology 1991; 100:482.
Venkov, CD, Rankin, AB, Vaughan, DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94:727.
Voetberg, GA, Netelenbos, JC, Kenemans, P, et al. Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone: Effect on calcium and lipid metabolism. J Clin Endocrinol Metab 1994; 79:1465.
Wagner, JD, Clarkson, TB, St Clair, RW, et al. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 1991; 88:1995.
Walsh, BW, Schiff, I, Rosner, B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325:1196.
Weiner, CP, Lizasoain, I, Baylis, SA, et al. Induction of calcium-independent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994; 91:5212.
Weinstein, L, Bewtra, C, Gallagher, JC. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol 1990; 162:153.
Whitehead, MI, Hillard, TC, Crook, D. The role and use of progestogens. Obstet Gynecol 1990; 75(S4):59s.
Whitehead, MI, Lobo, RA. Progestagen use in postmenopausal women. Consensus Conference. Lancet; 2:1243.
Williams, JK, Adams, MR, Klopfenstein, HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81:1680.
Williams, JK, Honore, EK, Washburn, SA, Clarkson, TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994; 24:1757.
Williams, SR, Frenchek, B, Speroff, L, et al. A study on combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. Am J Obstet Gynecol 1990; 162:438.
Wolfe, BM, Huff, MW. Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women. Metabolism 1995; 44:410.
Wollter-Svensson, LO, Stadberg, E, Andersson, K, et al. Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: Effects on lipid and lipoprotein metabolism. Maturitas 1995; 22:199.
Woodruff, JD, Pickar, JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994; 170:1213.
Yancey, MK, Stone, IK, Hannan, CJ. Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens. Fertil Steril 1990; 54:778.
